Murine monoclonal antibody 26 raised against tetanus toxoid cross-reacts with β2-glycoprotein I: Its characteristics and role in molecular mimicry

American Journal of Reproductive Immunology

Volumn 61, Issue 1, 2009, Pages 39-51

  Inic Kanada, Aleksandra ^a   Stojanovic, Marijana ^a   Zivkovic, Irena ^a   Kosec, Dusko ^a   Micic, Mileva ^a   Petrusic, Vladimir ^a   Zivancevic Simonovic, Snezana ^b   Dimitrijevic, Ljiljana ^a  

^a Institute of Virology   (Serbia)

^b UNIVERSITY OF KRAGUJEVAC   (Serbia)

Author keywords

2 glycoprotein I; Antiphospholipid syndrome; Fetal loss; Molecular mimicry; Tetanus toxoid

Indexed keywords

BETA2 GLYCOPROTEIN 1; TETANUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ANTIPHOSPHOLIPID SYNDROME; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CROSS REACTION; FEMALE; FETUS; FETUS RESORPTION; IMMUNOASSAY; IMMUNOPATHOGENESIS; IN VITRO STUDY; IN VIVO STUDY; INTRAUTERINE GROWTH RETARDATION; MALE; MOLECULAR MIMICRY; MOUSE; NONHUMAN; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION;

ANIMALS; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; APOPTOSIS; BETA 2-GLYCOPROTEIN I; CELLS, CULTURED; CROSS REACTIONS; FEMALE; MICE; MICE, INBRED BALB C; MOLECULAR MIMICRY; TETANUS TOXOID;

EID: 57749199106     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2008.00660.x     Document Type: Article

References (37)

1. McNeil HP, Chesterman CN, Krilis SA: Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 1991; 49:193-280. Review.
2. Lockshin MD: Antiphospholipid antibody syndrome. Rheum Dis Clin North Am 1994; 20:45-59. Review.
3. Arvieux J, Regnault V, Hachulla E, Darnige L, Roussel B, Bensa JC: Heterogeneity and immunochemical properties of anti-beta2-glycoprotein I autoantibodies. Thromb Haemost 1998; 80:393-398.
4. Piona A, La Rosa L, Tincani A, Faden D, Magro G, Grasso S, Nicoletti F, Balestrieri G, Meroni PL: Placental thrombosis and fetal loss after passive transfer of mouse lupus monoclonal or human polyclonal anti-cardiolipin antibodies in pregnant naive BALB/c mice. Scand J Immunol 1995; 41:427-432.
5. Blank M, Cohen J, Toder V, Shoenfeld Y: Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anticardiolipin antibodies. Proc Natl Acad Sci USA 1991; 88:3069-3073.
6. Branch DW, Dudley DJ, Mitchell MD, Creighton KA, Abbott TM, Hammond EH, Daynes RA: Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: A model for autoimmune fetal loss. Am J Obstet Gynecol 1990; 63(1 Pt 1):210-216.
7. Roubey RA, Pratt CW, Buyon JP, Winfield JB: Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I. J Clin Invest 1992; 90:1100-1104.
8. Bas de Laat H, Derksen RH, de Groot PG: Beta2-glycoprotein I, the playmaker of the antiphospholipid syndrome. Clin Immunol 2004; 112:161-168. Review.
9. Giannakopoulos B, Passam F, Rahgozar S, Krilis SA: Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood 2007; 109:422-430.
10. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA: Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: Beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87:4120-4124.
11. Roubey RA, Eisenberg RA, Harper MF, Winfield JB: "Anticardiolipin" autoantibodies recognize beta 2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding. J Immunol 1995; 154:954-960.
12. Croxford JH, Anger HA, Miller SD: Viral delivery of an epitope from Haemophilus influenzae induces central nervous system autoimmune disease by molecular mimicry. J Immunol 2005; 174:907-917.
13. Samarkos M, Vaiopoulos G: The role of infections in the pathogenesis of autoimmune diseases. Curr Drug Targets Inflamm Allergy 2005; 4:99-103.
14. Stojanović M, Inić-Kanada A, Popović Z, Zivković I, Dimitrijević L: Changes in pools of autoantibodies and anti-bacterial antibodies in patients suffering from recurrent infections of the urinary tract and undergoing bacterial immunization treatment. Immunol Lett 2004; 94:123-133.
15. Farrar JJ, Yen LM, Cook T, Fairweather N, Binh N, Parry J, Parry CM: Neurological aspects of tropical disease: Tetanus. J Neurol Neurosurg Psychiatry 2000; 69:292-301.
16. Blank M, Eisenstein M, Ascherson RA, Cervera R, Schoenfeld Y: The infectious origin of the antiphospholipid syndrome. In Infection and Autoimmunity, Y Schoenfeld, N Rose (eds). Amsterdam, Elsevier, 2004, pp 473-490.
17. European Bioinformatics Institute [cited 2008 June 2]: http://www.ebi.ac.uk/t-coffee.
18. Blank M, Krause I, Fridkin M, Keller N, Kopolovic J, Goldberg I, Tobar A, Shoenfeld Y: Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest 2002; 109:797-804.
19. Hunt JE, McNeil HP, Morgan GJ, Crameri RM, Krilis SA: A phospholipid -beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus 1992; 1:75-81.
20. Seatović S, Inić-Kanada A, Stojanović M, Zivković I, Jankov RM, Dimitrijević L: Development of sandwich enzyme-linked immunosorbent assay for determination of tetanus toxoid concentration. J Immunoassay Immunochem 2004; 25:31-44.
21. Petrićević M, Inić A, Jankov R, Dimitrijević LJ: Two new murine monoclonal antibodies raised against human IgG. J Serb Chem Soc 2001; 66:323-330.
22. Cirić B, Radulović M, Dimitrijević LJ, Jankov RM: Effect of valency on binding properties of the antihuman IgM monoclonal antibody 202. Hybridoma 1995; 14:537-544.
23. Gharavi AE, Harris EN, Asherson RA, Hughes GR: Anticardiolipin antibodies: Isotype distribution and phospholipid specificity. Ann Rheum Dis 1987; 46:1-6.
24. Cohen JJ: Programmed cell death in murine myeloid leukaemia cells. Photochem Photobiol 1991; 72:114-120.
25. Reid S, Cross R, Snow EC: Combined Hoechst 33342 and merocyanine 540 staining to examine murine B cell cycle stage, viability and apoptosis. J Immunol Methods 1996; 192:43-54.
26. Di Simone N, Meroni PL, de Papa N, Raschi E, Caliandro D, De Carolis CS, Khamashta MA, Atsumi T, Hughes GR, Balestrieri G, Tincani A, Casali P, Caruso A: Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. Arthritis Rheum 2000; 43:140-150.
27. Shoenfeld Y, Blank M, Cervera R, Font J, Raschi E, Meroni PL: Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis 2006; 65:2-6. Review.
28. Willems GM, Janssen MP, Pelsers MM, Comfurius P, Galli M, Zwaal RF, Bevers EM: Role of divalency in the high-affinity binding of anticardiolipin antibody beta 2-glycoprotein I complexes to lipid membranes. Biochemistry 1996; 35:13833-13842.
29. Horkko S, Miller E, Dudi E, Reaven P, Curtiss LK, Zvaifler NJ, Terkeltaub R, Pierangeli SS, Branch DW, Palinski W, Witztum JL: Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest 1996; 98:815-825.
30. Rauch J, Subang R, Paolo D'agnillo P, Jason S, Koh JS, Jerrold S, Levine JS: Apoptosis and the antiphospholipid syndrome. J Autoimmun 2000; 2:231-235.
31. Price BE, Rauch J, Shia MA, Walsh MA, Lieberthal W, Gilligan HM, O'Laughlin T, Koh JS, Levine JS: Anti-phospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a beta 2-glycoprotein I-dependent manner. J Immunol 1996; 157:2201-2208.
32. Ronchetti A, Rovere P, Iezzi G, Galati G, Heltai S, Protti MP, Garancini MP, Manfredi AA, Rugarli C, Bellone M: Immunogenicity of apoptotic cells in vivo: Role of antigen load, antigen-presenting cells, and cytokines. J Immunol 1999; 163:130-136.
33. D'Agnillo P, Levine JS, Subang R, Rauch J: Prothrombin binds to the surface of apoptotic, but not viable, cells and serves as a target of lupus anticoagulant autoantibodies. J Immunol 2003; 170:3408-3422.
34. van Engeland M, Kuijpers HJ, Ramaekers FC, Reutelingsperger CP, Schutte B: Plasma membrane alterations and cytoskeletal changes in apoptosis. Exp Cell Res 1997; 235:421.
35. Dawood F, Farquharson R, Quenby S: Recurrent miscarriage. Curr Obstet Gynaecol 2004; 14:247-253.
36. Pampfer S, Donnay I: Apoptosis at the time of embryo implantation in mouse and rat. Cell Death Differ 1999; 6:533-545.
37. Akcali KC, Khan SA, Moulton BC: Effect of decidualization on the expression of bax and bcl-2 in the rat uterine endometrium. Endocrinology 1996; 137:3123-3131.